These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 28189812

  • 1. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
    He R, Yin C.
    Acta Biomater; 2017 Apr 15; 53():355-366. PubMed ID: 28189812
    [Abstract] [Full Text] [Related]

  • 2. Intracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acid.
    Yin S, Huai J, Chen X, Yang Y, Zhang X, Gan Y, Wang G, Gu X, Li J.
    Acta Biomater; 2015 Oct 15; 26():274-85. PubMed ID: 26300335
    [Abstract] [Full Text] [Related]

  • 3. Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models.
    Zhang Y, Zhang H, Wu W, Zhang F, Liu S, Wang R, Sun Y, Tong T, Jing X.
    Int J Nanomedicine; 2014 Oct 15; 9():2019-30. PubMed ID: 24790440
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
    Wang X, Chen Y, Dahmani FZ, Yin L, Zhou J, Yao J.
    Biomaterials; 2014 Aug 15; 35(26):7654-65. PubMed ID: 24927684
    [Abstract] [Full Text] [Related]

  • 6. Paclitaxel loaded magnetic nanocomposites with folate modified chitosan/carboxymethyl surface; a vehicle for imaging and targeted drug delivery.
    Bano S, Afzal M, Waraich MM, Alamgir K, Nazir S.
    Int J Pharm; 2016 Nov 20; 513(1-2):554-563. PubMed ID: 27651326
    [Abstract] [Full Text] [Related]

  • 7. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
    Wang F, Yang S, Hua D, Yuan J, Huang C, Gao Q.
    J Biomater Sci Polym Ed; 2016 Nov 20; 27(3):276-89. PubMed ID: 26578298
    [Abstract] [Full Text] [Related]

  • 8. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy.
    Shan L, Zhuo X, Zhang F, Dai Y, Zhu G, Yung BC, Fan W, Zhai K, Jacobson O, Kiesewetter DO, Ma Y, Gao G, Chen X.
    Theranostics; 2018 Nov 20; 8(7):2018-2030. PubMed ID: 29556370
    [Abstract] [Full Text] [Related]

  • 9. Folate-Modified Poly(malic acid) Graft Polymeric Nanoparticles for Targeted Delivery of Doxorubicin: Synthesis, Characterization and Folate Receptor Expressed Cell Specificity.
    Yang Y, Li N, Nie Y, Sheng M, Yue D, Wang G, Tang JZ, Gu Z.
    J Biomed Nanotechnol; 2015 Sep 20; 11(9):1628-39. PubMed ID: 26485931
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
    Song RF, Li XJ, Cheng XL, Fu AR, Wang YH, Feng YJ, Xiong Y.
    Oncol Rep; 2014 Oct 20; 32(4):1481-8. PubMed ID: 25051142
    [Abstract] [Full Text] [Related]

  • 12. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier.
    Vinothini K, Rajendran NK, Ramu A, Elumalai N, Rajan M.
    Biomed Pharmacother; 2019 Feb 20; 110():906-917. PubMed ID: 30572195
    [Abstract] [Full Text] [Related]

  • 13. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
    Liu Y, Sun J, Cao W, Yang J, Lian H, Li X, Sun Y, Wang Y, Wang S, He Z.
    Int J Pharm; 2011 Dec 12; 421(1):160-9. PubMed ID: 21945183
    [Abstract] [Full Text] [Related]

  • 14. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
    Yin T, Wang L, Yin L, Zhou J, Huo M.
    Biomaterials; 2015 Aug 12; 61():10-25. PubMed ID: 25996409
    [Abstract] [Full Text] [Related]

  • 15. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J, Tang C, Yin C.
    Acta Biomater; 2017 Jan 01; 47():81-90. PubMed ID: 27729232
    [Abstract] [Full Text] [Related]

  • 16. Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.
    Cheng LC, Jiang Y, Xie Y, Qiu LL, Yang Q, Lu HY.
    Oncotarget; 2017 Jan 10; 8(2):3315-3326. PubMed ID: 27926514
    [Abstract] [Full Text] [Related]

  • 17. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M, Shi K, Tang X, Wei J, Cun X, Chen X, Yu Q, Zhang Z, He Q.
    Eur J Pharm Sci; 2018 Nov 01; 124():240-248. PubMed ID: 30071282
    [Abstract] [Full Text] [Related]

  • 18. Doxorubicin-Loaded Micelles Based on Folic Acid Conjugated pH-Dependent Thermo-Sensitive Copolymer: In Vitro and In Vivo Evaluation.
    Zhao H, Tao L, Yu R, Yuan H, Lan M.
    J Nanosci Nanotechnol; 2015 Aug 01; 15(8):5553-8. PubMed ID: 26369116
    [Abstract] [Full Text] [Related]

  • 19. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, Choi K, Kwon IC, Kim K.
    J Control Release; 2013 Dec 28; 172(3):823-31. PubMed ID: 24035978
    [Abstract] [Full Text] [Related]

  • 20. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
    Chen G, Svirskis D, Lu W, Ying M, Huang Y, Wen J.
    J Control Release; 2018 May 10; 277():142-153. PubMed ID: 29548985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.